Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratesWith |
gptkb:Immunomedics,_Inc.
|
| gptkbp:developedTechnology |
Dock-and-Lock (DNL) platform
|
| gptkbp:focusesOn |
cancer therapeutics
radioimmunotherapy |
| gptkbp:foundedBy |
gptkb:David_M._Goldenberg
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
Morris Plains, New Jersey, USA
|
| gptkbp:parentCompany |
gptkb:Immunomedics,_Inc.
|
| gptkbp:bfsParent |
gptkb:David_M._Goldenberg
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
IBC Pharmaceuticals, Inc.
|